Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Metaxalone vs Tizanidine on Driving and Cognition
NCT06382662Phase 4Completed
- Sponsor
- Primus Pharmaceuticals
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of metaxalone in Muscle spasm (2 arms), sponsored by Primus Pharmaceuticals. Primary endpoints: Standard Deviation of Lateral Position, no Traffic at 30 minutes, Standard Deviation of Lateral Position, Oncoming Traffic at 30 minutes and 1 more. Started Apr 2024; status: completed.
02
Drugs
metaxalone
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NCT06382662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06382662.